Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

Hailee Steinfeld will feature in a Novartis Super Bowl 2025 commercial on breast cancer awareness, a significant engagement ...

SALES FORECAST: Novartis's sales are forecast at $12.78 billion, according to analysts' estimates compiled by Visible Alpha. This compares with $11.42 billion the year before. Shares rose 5.1% over ...

Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

In Novartis Pharms. Corp. v. Torrent Pharma Inc., the U. S. Court of Appeals for the Federal Circuit shut down efforts to market a generic version of the heart disease drug ENTRESTO which is sold ...

BTS's Jungkook declined Usher's offer to perform at the 2024 Super Bowl halftime show due to his packed military service ...

Roche descendant André Hoffmann talks pharma, feuds and ESG as he takes a stand against ‘arrogance’ of Trump and Musk ...

Research from the Tufts Center for the Study of Drug Development’s PACT Consortium shows DCTs encourage higher participation ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

Exclusive data and analysis show why counsel in some regions may demand stronger DEI compliance from law firms than their ...